Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PCG vs MRNA✓SelectedUSD · MRNAPCG vs MRNA performance historyLatest closeAs of+1.26%11/18
Stock and ETF performance explorer

PCG vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-14.0%
MRNA return
+703.6%
Excess return
-717.6%
Maximum drawdown
-37.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.3%-4.8%+6.1%+1.3%
7D+4.7%-20.9%+25.5%+4.7%
30D+4.4%-13.3%+17.7%+4.4%
3M-22.7%+212.6%-235.3%-22.4%
6M-12.9%+309.0%-321.9%-13.1%
YTD-13.8%+567.3%-581.1%-14.1%
1Y-14.0%+689.7%-703.7%-14.6%
All-14.0%+703.6%-717.6%-14.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling